KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares Outstanding
Ratios

Biogen (BIIB) Long-Term Debt Repayments (2017 - 2025)

Biogen has reported Long-Term Debt Repayments over the past 10 years, most recently at $1.8 billion for Q2 2025.

  • For Q2 2025, Long-Term Debt Repayments rose 600.0% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, up 169.23%, while the annual FY2025 figure was $1.8 billion, 169.23% up from the prior year.
  • Long-Term Debt Repayments for Q2 2025 was $1.8 billion at Biogen, up from $250.0 million in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $1.8 billion in Q2 2025 and troughed at -$1.0 billion in Q4 2022.
  • A 5-year average of $294.3 million and a median of $169.3 million in 2021 define the central range for Long-Term Debt Repayments.
  • On a YoY basis, Long-Term Debt Repayments climbed as much as 7162.32% in 2022 and fell as far as 489.53% in 2022.
  • Year by year, Long-Term Debt Repayments stood at -$170.0 million in 2021, then tumbled by 489.53% to -$1.0 billion in 2022, then skyrocketed by 164.86% to $650.0 million in 2023, then plummeted by 61.54% to $250.0 million in 2024, then surged by 600.0% to $1.8 billion in 2025.
  • Business Quant data shows Long-Term Debt Repayments for BIIB at $1.8 billion in Q2 2025, $250.0 million in Q2 2024, and $400.0 million in Q1 2024.